Podcasts

#41 – We (Still) Hope Michael Pollan Changes His Mind

The crew reviews Michael Pollan’s recent New York Times Op-Ed “How Should We Do Drugs Now?”

Apple
Podcasts
Google Podcasts
Spotify
Stitcher
Radio Public
Deezer
RSS
The crew reviews Michael Pollan’s recent New York Times Op-Ed “How Should We Do Drugs Now?”

Co-hosts: Neşe Devenot, Brian Normand, David Nickles, Brian Pace. Editor: Matt Payne

Additional links:

Michael Pollan: Not So Fast on Psychedelic Mushrooms | New York Times

#1 – We Hope Michael Pollan Changes His Mind | Plus Three podcast

Michael Pollan worries we don’t know enough to legalise psychedelic drugs | The Guardian

Watch

Read more

Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript

Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript

In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.

Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript

Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript

In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.

Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript

Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript

In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.

Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript

Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript

In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.